Creatine Safety & Tolerability in Huntington's Disease

Clinical trial NCT01412151 · COMPLETED

Trial details

NCT number: NCT01412151
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington's Disease (HD)

Start date: 2005-04-01
Primary completion: 2011-11-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.